Cardiac Ablation Devices Market Size & Share | Report 2031
Cardiac Ablation Devices Market Size & Share | Report 2031
Segments - Cardiac Ablation Devices Market by Products (Radiofrequency (RF) Ablators, Electrical Ablators, Cryoablation Devices, and Ultrasound Ablators), Applications (Tachycardia, Open Surgery, and Cardiac Rhythm Management), End-users (Hospitals, Ambulatory Surgical Centers, Clinics, and Others), and Regions (Asia Pacific, North America, Latin America, Europe, and the Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2023 – 2031
Upcoming
| Report ID :HC-546
| 4.4 Rating
| 61 Reviews
| 190 Pages
| Format :
Report Description
Cardiac Ablation Devices Market Outlook 2031
The global cardiac ablation devices market size was valued at USD XX Billion in 2022 and is projected to reach USD XX Billion by 2031, expanding at a CAGR of XX% during the forecast period 2023 - 2031. The growth of the market is attributed to the rising prevalence of cardiovascular diseases.
Cardiac ablation is a surgical procedure that requires correction of rhythmic problems of the heart. The procedure includes scarring and deterioration of tissues that causes heart rhythm abnormality. In certain cases, cardiac ablation can help to avoid an arrhythmia. This is done by preventing irregular electrical signals to enter into the patient's heart.
Cardiac ablation involves inserting long, flexible tubes called catheters into a vein or artery, which delivers energy in a form of heat or cold to the tissues in the heart that triggers an arrhythmia. Increasing number of patients suffering from cardiovascular diseases such as arrhythmia is expected to drive the demand for cardiac ablation devices in the coming years.
According to the World Health Organization (WHO), around 17 million people die each year from cardiovascular diseases. Out of the total death count, heart attacks account for nearly 85 percent of deaths.
Cardiac Ablation Devices Market Drivers, Restraints, Trends, and Opportunities
-
Rising number of people with cardiac arrhythmia and growing geriatric population are the driving the cardiac ablation devices market growth.
-
Increasing preference for minimally invasive surgeries and rising awareness regarding cardiac ablation devices are anticipated to spur the cardiac ablation devices market growth.
-
Growing number of ablation centers is speculated to boost the cardiac ablation market.
-
Stringent regulations and risks related to cardiac ablation procedures can hamper the market opportunities during the forecast period.
Scope of Cardiac Ablation Devices Market Report
The report on the global cardiac ablation devices market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
|
Attributes |
Details |
|
Report Title |
Cardiac Ablation Devices Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
|
Base Year |
2022 |
|
Historic Data |
2016–2021 |
|
Forecast Period |
2023–2031 |
|
Segmentation |
Products (Radiofrequency (RF) Ablators, Electrical Ablators, Cryoablation Devices, Ultrasound Ablators), Applications (Tachycardia, Open Surgery, and Cardiac Rhythm Management), and End-users (Hospitals, Ambulatory Surgical Centers, Clinics, and Others) |
|
Regional Scope |
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
|
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast |
|
Key Players Covered in the Report |
Epix Therapeutics, Acutus Medical, Medtronic, AtriCure, Inc., Biosense Webster, Inc., St Jude Medical, and Abbott |
Global Cardiac Ablation Devices Market Segment Insights
Electric ablators segment to account a large market share
Based on products, the cardiac ablation devices market share is segmented into cryoablation devices, radiofrequency ablators, ultrasonic ablators, and electrical ablators. In 2020, electric ablators segment to account for a large market share during the forecast period. Argon plasma/beam coagulators and irreversible electroporation devices are two types of electric ablators. Increasing number of R&D activities is driving the growth of the market segment.
Cardiac rhythm management segment to account for key market share
In terms of applications, the cardiac ablation devices market share is segmented into tachycardia, open surgery, and cardiac rhythm management. The cardiac rhythm management to account for a key market share during the forecast period. Cardiac rhythm management devices are commonly used to treat heart disease and heart rhythmic disorders.
Hospitals segment to dominate the market
On the basis of end-users, the market is classified as hospitals, ambulatory surgery centers, clinics, and others. In 2020, the hospital segment accounted for more than USD 1.5 billion in revenue. The presence of modern healthcare infrastructure and trained clinicians improve procedural adoption rates in the hospitals. The availability of latest technology in hospitals is driving the growth of the market segment.
North America to dominate the market
Based on regions, the market is segregated into Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. In 2020, North America held a large market share owing to the rising healthcare expenditure, increasing disposable income, and the availability of latest technology are contributing to the regional market growth.
North America is expected to dominate the market during the forecast period owing to the rising prevalence of cardiac arrhythmias, established healthcare infrastructures, high volumes of catheterization, increasing government funding, and growing patient awareness in countries such as the US and Canada.
Segments
The global cardiac ablation devices market has been segmented based on
Products
- Radiofrequency (RF) Ablators
- Electrical Ablators
- Cryoablation Devices
- Ultrasound Ablators
Applications
- Tachycardia
- Open Surgery
- Cardiac Rhythm Management
End-users
- Hospitals
- Ambulatory SurgicalCcenters
- Clinics
- Others
Regions
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
Key Players
- Acutus Medical
- Medtronic
- AtriCure, Inc.
- Biosense Webster, Inc.
- St Jude Medical
- Abbott
- Epix Therapeutics
Competitive Landscape
Some of the leading manufacturers in the global cardiac ablation devices market are Epix Therapeutics, Acutus Medical, Medtronic, AtriCure, Inc., Biosense Webster, Inc., St Jude Medical, Abbott.
Companies are focusing on providing advanced technology devices to hospitals and clinics for the treatment of patients suffering from arrhythmia.
Frequently Asked Questions
The Cardiac Ablation Devices Market is studied from 2023 - 2031.
In 2020, electric ablators segment to account for a large market share during the forecast period.
North America held a large market share owing to the rising healthcare expenditure, increasing disposable income, and the availability of latest technology are contributing to the regional market growth.
Some of the leading manufacturers in the global cardiac ablation devices market are Epix Therapeutics, Acutus Medical, Medtronic, AtriCure, Inc., Biosense Webster, Inc., St Jude Medical, Abbott.
Table Of Content
1. Executive Summary2. Assumptions and Acronyms Used
3. Research Methodology
4. Cardiac Ablation Devices Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Cardiac Ablation Devices Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Cardiac Ablation Devices Market - Supply Chain
4.5. Global Cardiac Ablation Devices Market Forecast
4.5.1. Cardiac Ablation Devices Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Cardiac Ablation Devices Market Size (000’ Units) and Y-o-Y Growth
4.5.3. Cardiac Ablation Devices Market Absolute $ Opportunity
5. Global Cardiac Ablation Devices Market Analysis and Forecast by Applications
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Applications
5.2.2. Y-o-Y Growth Projections by Applications
5.3. Cardiac Ablation Devices Market Size and Volume Forecast by Applications
5.3.1. Tachycardia
5.3.2. Open Surgery
5.3.3. Cardiac Rhythm Management
5.4. Absolute $ Opportunity Assessment by Applications
5.5. Market Attractiveness/Growth Potential Analysis by Applications
6. Global Cardiac Ablation Devices Market Analysis and Forecast by End Users
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by End Users
6.2.2. Y-o-Y Growth Projections by End Users
6.3. Cardiac Ablation Devices Market Size and Volume Forecast by End Users
6.3.1. Hospitals
6.3.2. Ambulatory SurgicalCcenters
6.3.3. Clinics
6.3.4. Others
6.4. Absolute $ Opportunity Assessment by End Users
6.5. Market Attractiveness/Growth Potential Analysis by End Users
7. Global Cardiac Ablation Devices Market Analysis and Forecast by Region
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Region
7.2.2. Y-o-Y Growth Projections by Region
7.3. Cardiac Ablation Devices Market Size and Volume Forecast by Region
7.3.1. North America
7.3.2. Latin America
7.3.3. Europe
7.3.4. Asia Pacific
7.3.5. Middle East and Africa (MEA)
7.4. Absolute $ Opportunity Assessment by Region
7.5. Market Attractiveness/Growth Potential Analysis by Region
7.6. Global Cardiac Ablation Devices Demand Share Forecast, 2019-2026
8. North America Cardiac Ablation Devices Market Analysis and Forecast
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis by Country
8.1.2. Y-o-Y Growth Projections by Country
8.2. North America Cardiac Ablation Devices Market Size and Volume Forecast by Country
8.2.1. U.S.
8.2.2. Canada
8.3. Absolute $ Opportunity Assessment by Country
8.4. North America Cardiac Ablation Devices Market Size and Volume Forecast by Applications
8.4.1. Tachycardia
8.4.2. Open Surgery
8.4.3. Cardiac Rhythm Management
8.5. Basis Point Share (BPS) Analysis by Applications
8.6. Y-o-Y Growth Projections by Applications
8.7. North America Cardiac Ablation Devices Market Size and Volume Forecast by End Users
8.7.1. Hospitals
8.7.2. Ambulatory SurgicalCcenters
8.7.3. Clinics
8.7.4. Others
8.8. Basis Point Share (BPS) Analysis by End Users
8.9. Y-o-Y Growth Projections by End Users
8.10. Market Attractiveness/Growth Potential Analysis
8.10.1. By Country
8.10.2. By Product Type
8.10.3. By Application
8.11. North America Cardiac Ablation Devices Demand Share Forecast, 2019-2026
9. Latin America Cardiac Ablation Devices Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.1.3. Latin America Average Pricing Analysis
9.2. Latin America Cardiac Ablation Devices Market Size and Volume Forecast by Country
9.2.1. Brazil
9.2.2. Mexico
9.2.3. Rest of Latin America
9.3. Absolute $ Opportunity Assessment by Country
9.4. Latin America Cardiac Ablation Devices Market Size and Volume Forecast by Applications
9.4.1. Tachycardia
9.4.2. Open Surgery
9.4.3. Cardiac Rhythm Management
9.5. Basis Point Share (BPS) Analysis by Applications
9.6. Y-o-Y Growth Projections by Applications
9.7. Latin America Cardiac Ablation Devices Market Size and Volume Forecast by End Users
9.7.1. Hospitals
9.7.2. Ambulatory SurgicalCcenters
9.7.3. Clinics
9.7.4. Others
9.8. Basis Point Share (BPS) Analysis by End Users
9.9. Y-o-Y Growth Projections by End Users
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.11. Latin America Cardiac Ablation Devices Demand Share Forecast, 2019-2026
10. Europe Cardiac Ablation Devices Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Europe Average Pricing Analysis
10.2. Europe Cardiac Ablation Devices Market Size and Volume Forecast by Country
10.2.1. Germany
10.2.2. France
10.2.3. Italy
10.2.4. U.K.
10.2.5. Spain
10.2.6. Russia
10.2.7. Rest of Europe
10.3. Absolute $ Opportunity Assessment by Country
10.4. Europe Cardiac Ablation Devices Market Size and Volume Forecast by Applications
10.4.1. Tachycardia
10.4.2. Open Surgery
10.4.3. Cardiac Rhythm Management
10.5. Basis Point Share (BPS) Analysis by Applications
10.6. Y-o-Y Growth Projections by Applications
10.7. Europe Cardiac Ablation Devices Market Size and Volume Forecast by End Users
10.7.1. Hospitals
10.7.2. Ambulatory SurgicalCcenters
10.7.3. Clinics
10.7.4. Others
10.8. Basis Point Share (BPS) Analysis by End Users
10.9. Y-o-Y Growth Projections by End Users
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.11. Europe Cardiac Ablation Devices Demand Share Forecast, 2019-2026
11. Asia Pacific Cardiac Ablation Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Asia Pacific Average Pricing Analysis
11.2. Asia Pacific Cardiac Ablation Devices Market Size and Volume Forecast by Country
11.2.1. China
11.2.2. Japan
11.2.3. South Korea
11.2.4. India
11.2.5. Australia
11.2.6. Rest of Asia Pacific (APAC)
11.3. Absolute $ Opportunity Assessment by Country
11.4. Asia Pacific Cardiac Ablation Devices Market Size and Volume Forecast by Applications
11.4.1. Tachycardia
11.4.2. Open Surgery
11.4.3. Cardiac Rhythm Management
11.5. Basis Point Share (BPS) Analysis by Applications
11.6. Y-o-Y Growth Projections by Applications
11.7. Asia Pacific Cardiac Ablation Devices Market Size and Volume Forecast by End Users
11.7.1. Hospitals
11.7.2. Ambulatory SurgicalCcenters
11.7.3. Clinics
11.7.4. Others
11.8. Basis Point Share (BPS) Analysis by End Users
11.9. Y-o-Y Growth Projections by End Users
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.11. Asia Pacific Cardiac Ablation Devices Demand Share Forecast, 2019-2026
12. Middle East & Africa Cardiac Ablation Devices Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Middle East & Africa Average Pricing Analysis
12.2. Middle East & Africa Cardiac Ablation Devices Market Size and Volume Forecast by Country
12.2.1. Saudi Arabia
12.2.2. South Africa
12.2.3. UAE
12.2.4. Rest of Middle East & Africa (MEA)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Middle East & Africa Cardiac Ablation Devices Market Size and Volume Forecast by Applications
12.4.1. Tachycardia
12.4.2. Open Surgery
12.4.3. Cardiac Rhythm Management
12.5. Basis Point Share (BPS) Analysis by Applications
12.6. Y-o-Y Growth Projections by Applications
12.7. Middle East & Africa Cardiac Ablation Devices Market Size and Volume Forecast by End Users
12.7.1. Hospitals
12.7.2. Ambulatory SurgicalCcenters
12.7.3. Clinics
12.7.4. Others
12.8. Basis Point Share (BPS) Analysis by End Users
12.9. Y-o-Y Growth Projections by End Users
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.11. Middle East & Africa Cardiac Ablation Devices Demand Share Forecast, 2019-2026
13. Competition Landscape
13.1. Global Cardiac Ablation Devices Market: Market Share Analysis
13.2. Cardiac Ablation Devices Distributors and Customers
13.3. Cardiac Ablation Devices Market: Competitive Dashboard
13.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
13.4.1. Epix Therapeutics
13.4.2. Acutus Medical
13.4.3. Medtronic
13.4.4. AtriCure, Inc.
13.4.5. Biosense Webster, Inc.
13.4.6. St Jude Medical
13.4.7. Abbott
Methodology
Related Reports
Some other reports from this category!
Our Clients
